Showing results (31-40 of 57) with videos related to
Sort By:
Pageof 6
Frontiers in Neuroscience|April 15, 2017
Tau Pathology Distribution in Alzheimer's disease Corresponds Differentially to Cognition-Relevant Functional Brain NetworksOskar Hansson, Michel J Grothe, Tor Olof Strandberg, et al.Alzheimer'S Research & Therapy|August 9, 2018
Greater tau load and reduced cortical thickness in APOE ε4-negative Alzheimer's disease: a cohort studyNiklas Mattsson, Rik Ossenkoppele, Ruben Smith, et al.Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|December 12, 2018
Qualitative assessments of myocardial ischemia by cardiac MRI and coronary stenosis by invasive coronary angiography in relation to quantitative perfusion by positron emission tomography in patients with known or suspected stable coronary artery diseaseShahnaz Akil, Fredrik Hedeer, Marcus Carlsson, et al.Annals of Nuclear Medicine|December 14, 2017
Automatic lung segmentation in functional SPECT images using active shape models trained on reference lung shapes from CTGrigorios-Aris Cheimariotis, Mariam Al-Mashat, Kostas Haris, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 15, 2019
Predicting diagnosis and cognition with 18F-AV-1451 tau PET and structural MRI in Alzheimer's diseaseNiklas Mattsson, Philip S Insel, Michael Donohue, et al.Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|November 10, 2019
Appropriate coronary revascularization can be accomplished if myocardial perfusion is quantified by positron emission tomography prior to treatment decisionShahnaz Akil, Fredrik Hedeer, Jenny Oddstig, et al.Journal of Applied Physiology (Bethesda, Md. : 1985)|December 25, 2019
Increased pulmonary blood volume variation in patients with heart failure compared to healthy controls: a noninvasive, quantitative measure of heart failureMariam Al-Mashat, Jonas Jögi, Marcus Carlsson, et al.Parkinsonism & Related Disorders|August 30, 2025
CSF markers of neuroinflammation, synaptic dysfunction and [18F]DOPA-PET in Parkinson's diseaseKevin Oliveira Hauer, Sara Hall, Adjmal Nahimi, et al.Neurology|July 30, 2017
In vivo retention of 18F-AV-1451 in corticobasal syndromeRuben Smith, Michael Schöll, Håkan Widner, et al.Movement Disorders : Official Journal of the Movement Disorder Society|October 7, 2016
Increased basal ganglia binding of 18 F-AV-1451 in patients with progressive supranuclear palsyRuben Smith, Martin Schain, Christer Nilsson, et al.Pageof 6